Miri Polachek is an experienced executive and board member with a strong background in health-focused ventures and innovative management. Currently serving as the Chief Executive Officer at Amadeus Management and a Venture Partner at quadraScope Venture Fund, Miri Polachek actively supports ventures targeting aging and health improvement. Miri Polachek is also a board member at Klogenix Therapeutics, which develops anti-aging therapies, and has held various board roles at companies such as Myndlift, Reflect Innovation, and Israel Brain Technologies. Previously, Miri Polachek served as CEO of Joy Ventures, where significant contributions and investments were made in consumer mental health tech. Miri Polachek holds an MBA in Finance and Management from NYU Stern School of Business, an MA in Economics from Boston University, and a BA in Economics and Mathematics from Boston University.
Links